Read our previous insight-driven newsletters covering business, finance, economics and tech.
Plus: OpenAI is livid someone may have been loosey-goosey with its IP.
Plus: Is DeepSeek really a Sputnik moment?
Plus: Reid Hoffman wants to bring AI to cancer research.
Plus: Who are you calling an ‘advisor’?
A Q&A with Autumn Moulder, director of infrastructure and security at Cohere
Plus: Novo Nordisk gets investors excited again.
The Great Resignation is over. The Great Detachment is just beginning.
Plus: AI hype is contagious for biotech startups.